GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NDT Pharmaceuticals Inc (OTCPK:NDTP) » Definitions » 12-1 Month Momentum %

NDT Pharmaceuticals (NDT Pharmaceuticals) 12-1 Month Momentum % : -89.90% (As of Jun. 22, 2024)


View and export this data going back to 2006. Start your Free Trial

What is NDT Pharmaceuticals 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-22), NDT Pharmaceuticals's 12-1 Month Momentum % is -89.90%.

The industry rank for NDT Pharmaceuticals's 12-1 Month Momentum % or its related term are showing as below:

NDTP's 12-1 Month Momentum % is not ranked
in the Biotechnology industry.
Industry Median: -21.37 vs NDTP: -89.90

Competitive Comparison of NDT Pharmaceuticals's 12-1 Month Momentum %

For the Biotechnology subindustry, NDT Pharmaceuticals's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NDT Pharmaceuticals's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NDT Pharmaceuticals's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where NDT Pharmaceuticals's 12-1 Month Momentum % falls into.



NDT Pharmaceuticals  (OTCPK:NDTP) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NDT Pharmaceuticals  (OTCPK:NDTP) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


NDT Pharmaceuticals 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of NDT Pharmaceuticals's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


NDT Pharmaceuticals (NDT Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
7325 Oswego Road, Liverpool, NY, USA, 13090
NDT Pharmaceuticals Inc is a biotechnology company focused on developing revolutionary therapies for severe neurological disorders associated with traumatic brain injury. Its Nanoscale Particle Complex (NPC) technology represents the leading edge of phospholipid-based nano-encapsulation delivery systems (less than 100 nanometers in diameter; mean diameter of 40 nanometers in current liquid product samples with the capability to engineer significantly smaller nanocarrier particles) that create instant delivery of payloads into the bloodstream, beginning through the membranes of the mouth.
Executives
Francisco Kent Carasquero director, officer: Secretary 1057 EAST 21ST AVENUE, CANADA, VANCOUVER BC A1 V5V 1S6

NDT Pharmaceuticals (NDT Pharmaceuticals) Headlines

No Headlines